Exchange Traded Concepts, LLC Pacira Bio Sciences, Inc. Transaction History

Exchange Traded Concepts, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$25.5 - $31.51 $71,094 - $87,849	2,788 Added 5.73%	51,480 $1.47 Million
Q1 2024 Apr 15, 2024	BUY	$27.7 - $35.48 $928,365 - $1.19 Million	33,515 Added 220.83%	48,692 $1.42 Million
Q3 2023 Oct 18, 2023	BUY	$30.68 - $40.09 $465,630 - $608,445	15,177 New	15,177 $465,000
Q2 2022 Jul 20, 2022	BUY	$51.49 - $81.64 $10,915 - $17,307	212 Added 2.32%	9,355 $545,000
Q1 2022 Apr 26, 2022	SELL	$60.03 - $76.49 $32,476 - $41,381	-541 Reduced 5.59%	9,143 $698,000
Q4 2021 Jan 13, 2022	BUY	$47.97 - $62.21 $8,346 - $10,824	174 Added 1.83%	9,684 $583,000
Q3 2021 Oct 18, 2021	BUY	$54.64 - $61.3 $519,626 - $582,963	9,510 New	9,510 $533,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

Stay updated on Exchange Traded Concepts, LLC with notifications on news.